Clinical trials are a key driver of medical innovation and progress, but scientists have known for decades that the existing evidence base on drugs and medical devices is incomplete and biased due to the opacity of clinical trials. It opens the door to fraud and corruption and undermines both medical advances and public health objectives. This report explains how to implement clinical trial transparency.